Active, Not Recruiting
Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)
NCT03964090
- Conditions
- Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States